{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:02:15Z","timestamp":1790474535524,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,5]],"date-time":"2027-05-05T00:00:00Z","timestamp":1809475200000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UG1HD027915"],"award-info":[{"award-number":["UG1HD027915"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R24 HD113024"],"award-info":[{"award-number":["R24 HD113024"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.semperi.2025.152210","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:48:48Z","timestamp":1766692128000},"page":"152210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preeclampsia trials that changed practice"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-1328","authenticated-orcid":false,"given":"Eniola R.","family":"Ibirogba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Grasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-469X","authenticated-orcid":false,"given":"Maged M.","family":"Costantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0001","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1471-0528.14151","article-title":"The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancy","volume":"124","author":"Scaffidi","year":"2017","journal-title":"Bjog"},{"issue":"9461","key":"10.1016\/j.semperi.2025.152210_bib0002","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0003","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-Dose Aspirin Use During Pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.semperi.2025.152210_bib0004","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.semperi.2025.152210_bib0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N Engl J Med"},{"issue":"9575","key":"10.1016\/j.semperi.2025.152210_bib0006","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"8898","key":"10.1016\/j.semperi.2025.152210_bib0007","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"8842","key":"10.1016\/j.semperi.2025.152210_bib0008","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy","volume":"341","year":"1993","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.semperi.2025.152210_bib0009","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.semperi.2025.152210_bib0010","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semperi.2025.152210_bib0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0012","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.amepre.2021.01.032","article-title":"Aspirin Prophylaxis During Pregnancy: a Systematic Review and Meta-Analysis","volume":"61","author":"Choi","year":"2021","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100803","article-title":"Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis","volume":"5","author":"D'Antonio","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"10.1016\/j.semperi.2025.152210_bib0014","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"2 Pt 1","key":"10.1016\/j.semperi.2025.152210_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2s","key":"10.1016\/j.semperi.2025.152210_bib0016","doi-asserted-by":"crossref","first-page":"S1171","DOI":"10.1016\/j.ajog.2020.08.040","article-title":"The role of statins in the prevention of preeclampsia","volume":"226","author":"Smith","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152210_bib0017","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0018","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","article-title":"Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort","volume":"56","author":"Mongraw-Chaffin","year":"2010","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0019","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0020","doi-asserted-by":"crossref","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"25","key":"10.1016\/j.semperi.2025.152210_bib0021","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1080\/14767058.2021.1879785","article-title":"Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study","volume":"35","author":"Akbar","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.semperi.2025.152210_bib0022","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1055\/a-1798-1925","article-title":"INOVASIA Study: a Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High-Risk Patients","volume":"41","author":"Akbar","year":"2024","journal-title":"Am J Perinatol"},{"issue":"9","key":"10.1016\/j.semperi.2025.152210_bib0023","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia","volume":"144","author":"D\u00f6bert","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.semperi.2025.152210_bib0024","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"Bjog"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0025","doi-asserted-by":"crossref","first-page":"153.e1","DOI":"10.1016\/j.ajog.2023.02.016","article-title":"Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero","volume":"229","author":"Costantine","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0027","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"American College of O, Gynecologists' Committee on Practice B-O. ACOG Practice Bulletin No. 203: chronic Hypertension in Pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.semperi.2025.152210_bib0028","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for Mild Chronic Hypertension during Pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajog.2015.04.013","article-title":"SMFM Statement: benefit of antihypertensive therapy for mild-to-moderate chronic hypertension during pregnancy remains uncertain","volume":"213","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152210_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0031","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.ajog.2022.04.011","article-title":"Electronic address pso. Society for Maternal-Fetal Medicine Statement: antihypertensive therapy for mild chronic hypertension in pregnancy-The Chronic Hypertension and Pregnancy trial","volume":"227","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0032","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1800566","article-title":"Labor Induction versus Expectant Management in Low-Risk Nulliparous Women","volume":"379","author":"Grobman","year":"2018","journal-title":"N Engl J Med"},{"issue":"9181","key":"10.1016\/j.semperi.2025.152210_bib0033","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0034","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajog.2004.09.005","article-title":"Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial","volume":"192","author":"Beazley","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152210_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/10641955.2010.507840","article-title":"Dhawan V. Vitamin C and E supplementation does not reduce the risk of superimposed PE in pregnancy","volume":"30","author":"Kalpdev","year":"2011","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.semperi.2025.152210_bib0036","first-page":"273","article-title":"The effects of multi mineral-vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: an RCT","volume":"15","author":"Azami","year":"2017","journal-title":"Int J Reprod Biomed"},{"issue":"10","key":"10.1016\/j.semperi.2025.152210_bib0037","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/OGX.0b013e3182095366","article-title":"Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis","volume":"65","author":"Basaran","year":"2010","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0038","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2011.02.020","article-title":"Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis","volume":"204","author":"Conde-Agudelo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and Hemodynamic Evaluation of Sildenafil Citrate for Preeclampsia Treatment: a Randomized Controlled Trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5323","article-title":"Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: a Randomized Clinical Trial","volume":"3","author":"Pels","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.semperi.2025.152210_bib0041","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s10815-020-01971-8","article-title":"Three polymorphisms of renin-angiotensin system and preeclampsia risk","volume":"37","author":"Wang","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.semperi.2025.152210_bib0042","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"8963","key":"10.1016\/j.semperi.2025.152210_bib0043","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(95)91034-4","article-title":"Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"9321","key":"10.1016\/j.semperi.2025.152210_bib0044","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0045","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ajog.2003.12.057","article-title":"Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials","volume":"190","author":"Sibai","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152210_bib0046","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9378(97)70558-1","article-title":"The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial","volume":"176","author":"Witlin","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152210_bib0047","first-page":"217","article-title":"Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial","volume":"101","author":"Livingston","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9694","key":"10.1016\/j.semperi.2025.152210_bib0048","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"issue":"9986","key":"10.1016\/j.semperi.2025.152210_bib0049","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(14)61998-X","article-title":"Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial","volume":"385","author":"Broekhuijsen","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semperi.2025.152210_bib0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152210_bib0051","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28 and 34 weeks' gestation: a randomized controlled trial","volume":"76","author":"Odendaal","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152210_bib0052","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/10641950802601252","article-title":"Expectant management of severe preeclampsia remote from term: a structured systematic review","volume":"28","author":"Magee","year":"2009","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"10.1016\/j.semperi.2025.152210_bib0053","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0301-2115(02)00269-5","article-title":"Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation","volume":"107","author":"Vigil-De Gracia","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152210_bib0054","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajog.2011.07.017","article-title":"Evaluation and management of severe preeclampsia before 34 weeks' gestation","volume":"205","author":"Sibai","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152210_bib0055","doi-asserted-by":"crossref","first-page":"425.e1","DOI":"10.1016\/j.ajog.2013.08.016","article-title":"Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial","volume":"209","author":"Vigil-De Gracia","year":"2013","journal-title":"Am J Obstet Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:28:17Z","timestamp":1777955297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000525001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0146000525001879"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152210","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preeclampsia trials that changed practice","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152210"}}